Monitoring the Prevalence of Antimicrobial Resistance in Companion Animals: Results from Clinical Isolates in an Italian University Veterinary Hospital
Table 1
Distribution of the 863 specimens (total number and percentage) considering specimen type, from November 2020 to September 2022.
Specimen type
Total number
(%)
Dogs (690)
(%)
Cats (173)
(%)
Percentage of positive specimens (%)
Urine
474
54.92
383
55.51
91
52.60
32.38
Abdominal/pleural/peritoneal effusion
26
3.01
19
2.75
7
4.05
39.39
Bile
9
1.04
6
0.87
3
1.73
13.04
Biopsy
24
2.78
21
3.04
3
1.73
33.33
Blood culture
49
5.68
35
5.07
14
8.09
16.39
Ear swab
77
8.93
69
10.00
8
4.62
61.11
Exudate
15
1.74
10
1.45
5
2.89
53.57
Nasal swab
21
2.43
9
1.30
12
6.94
70.00
Respiratory tract lavage
7
0.81
7
1.01
0
0.00
31.82
Surgical site infection (SSI) and implants
36
4.17
31
4.49
5
2.89
67.92
Vaginal/uterine swab
43
4.98
34
4.93
9
5.20
76.79
Wound
41
4.75
29
4.20
12
6.94
78.85
Abcess
13
1.51
11
1.59
2
1.16
59.09
Other
28
3.24
26
3.77
2
1.16
59.57
Note: distribution of specimen type in dogs (n = 690) and cats (n = 173) is reported, and also the percentage of submitted specimens that tested positive.
